|
|
|
| |
|
|
| |
The latest Allergy news from News Medical |
|
|
|
 | | |  GLP-1 weight loss medications linked to significant drop in asthma flares New research presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26 % fall in the number of asthma exacerbations and a 14% drop in use of asthma inhaler reliever use. The study is by Simon Høj and Dr Kjell Erik Julius Håkansson, Copenhagen University Hospital, Copenhagen, Denmark and colleagues. | | | | |  New therapies could help type 1 diabetes care move beyond insulin alone Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune dysregulation, beta-cell stress, and preservation of endogenous beta-cell function. Teplizumab marks a major clinical milestone, but the review emphasizes that durable metabolic remission will likely require earlier screening, better patient selection, and sequential or combination therapies. | |
|
|
| | | | |  Bedfont® Scientific Ltd., an innovative leader in the medical breath analysis industry with almost 50 years of experience, is pleased to join thousands of healthcare experts at this year’s European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 at stand I03 to showcase its NObreath® and Gastrolyzer® range of non-invasive breath analysis devices. | | | | |  Today, 11-year-old Logan Fitzpatrick of Malverne, New York, spends his time playing baseball, practicing tae kwon do, painting, and cheering on the Mets and the Islanders. | | | | |  Making children laugh can build deep emotional connections and soothe their nervous systems, making them more resilient and open to new ideas, a leading child development expert tells us. | | | | |  Not all broken genes fail in the same way: some simply stop working, while others interfere with what still works. | |
|
|
|
|
|
|
|
